Agilent Technologies Inc. completed its acquisition of clinical pathology leader Biocare Medical.
The deal expands Agilent's pathology portfolio for clinical and research customers.
Management expects the transaction to boost top-line growth and margins within the first year.
The acquisition will also increase Agilent's non-instrument revenue mix.
Biocare will join Agilent's Life Sciences and Diagnostics Markets Group.
Financial terms of the deal remain undisclosed.